HID x EY – LSH Connect Sessions

We are excited to invite you to the upcoming HID x EY LSH Connect Sessions, where this edition’s central theme is dealmaking in the Life Sciences & Health ecosystem.
From investment trends to strategic M&A journeys, this session will spotlight the forces shaping today’s most impactful deals. Expect sharp insights, real‑world experiences, and plenty of inspiration for anyone passionate about LSH innovation and growth.

Program:
15:30 – 16:00 | Registration & drinks
16:00 – 17:00 | Keynote Talks & Panel Discussion
17:00 – 18:00 | Networking Reception
Meet and connect with peers from the life sciences & health community in an informal setting.

Speakers:

This edition features two outstanding speakers:

Felice Verduyn – van Weegen (EQT Life Sciences)
Felice will share a high‑level investor perspective on the current life sciences deal climate, both in the Netherlands and globally, drawing on her extensive experience in the VC landscape.

Peter Louwagie (SVP Corporate Development & BD&L, Genmab)
With 20 years of experience in Business Development, Licensing, M&A and strategic transactions, Peter played a key role in Genmab’s recent acquisition of Merus. He will discuss the story behind this deal, the journey leading up to it, and Genmab’s ambitions moving forward.

Be sure to register soon, as seats are limited.